# RMA Long Island IVF – FDA Inspection, Oct 20, 2010

Source: https://www.keypedia.com/records/fda_inspections/rma-long-island-ivf/aa83acbb-5e94-46e9-bea8-24fa6ce85e90
Source feed: FDA_Inspections

> FDA inspection 695053 of RMA Long Island IVF, October 20, 2010. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 695053
- Company Name: RMA Long Island IVF
- Inspection Date: 2010-10-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1229041 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/rma-long-island-ivf/d3a572d3-1795-41a8-840a-52327db22793)
- FDA Inspection 1163524 - 2022-03-01
- FDA Inspection 1076523 - 2018-12-13
- FDA Inspection 994705 - 2016-12-20
- FDA Inspection 900033 - 2014-10-16

Company: https://www.keypedia.com/companies/rma-long-island-ivf/cd54c3fa-c54b-41c1-a844-8eafdb85b4f3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
